Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Katrin van Beekum"'
Autor:
Tobias J. Weismüller, Robert Mahn, Jonel Trebicka, Christian P. Strassburg, Christian Jansen, Jacob Nattermann, Vittorio Branchi, Matthias Sampels, Jörg C. Kalff, Hanno Matthaei, Maria A. Gonzalez-Carmona, Steffen Manekeller, A Vogt, Michael Praktiknjo, Raphael Mohr, Katrin van Beekum, M Bolch
Publikováno v:
Alimentary Pharmacology & Therapeutics. 49:437-447
Background Chemotherapy with gemcitabine and cisplatin is the current standard for patients with unresectable cholangiocarcinoma. Local photodynamic therapy has also demonstrated benefit in patients with extrahepatic cholangiocarcinoma. Aim To evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5632f990ba1dd69b32ee5841b997264c
https://doi.org/10.1111/apt.15050
https://doi.org/10.1111/apt.15050
Autor:
Philipp Lingohr, Jörg C. Kalff, Katrin van Beekum, Maria A. Gonzalez-Carmona, Hojjat Ahmadzadehfar, Robert Hüneburg, Christian P. Strassburg, Carsten Meyer, Robert Mahn, Marieta Toma, A Vogt, Markus Essler, Hanno Matthaei, Patrick Kupczyk, Farsaneh Sadeghlar
Publikováno v:
Scandinavian journal of gastroenterology. 55(9)
The prognosis for advanced Hepatocellular carcinoma (HCC)is still very poor. Despite initial usefulness of immune checkpoint inhibitor (PD-1), phase 3 trials failed to show significant benefit of PD-1 inhibition with nivolumab or pembrolizumab in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4ba9ddb78651135e3bd4b7e5710c9cc
https://pubmed.ncbi.nlm.nih.gov/32692941
https://pubmed.ncbi.nlm.nih.gov/32692941
Autor:
Robert Mahn, Farsaneh Sadeghlar, Vittorio Branchi, Christian P. Strassburg, Tobias J. Weismüller, Raphael Mohr, Katrin van Beekum, Maria A. Gonzalez-Carmona, Miroslaw Kornek, Hanno Matthaei, I. Schmidt-Wolf, Marieta Toma, Jörg C. Kalff, A Vogt
Publikováno v:
Cancer Immunology, Immunotherapy
Introduction Gastrointestinal (GI) malignancies, such as cholangiocarcinoma, pancreatic carcinoma, and metastatic colorectal carcinoma, have a poor prognosis and effective therapeutic approaches are still challenging. Checkpoint inhibition with PD-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79d73275aafc487bdc9407fe242ce5a0
https://pubmed.ncbi.nlm.nih.gov/33180184
https://pubmed.ncbi.nlm.nih.gov/33180184